Activation of the IGF system stimulates proliferation, differentiation, angiogenesis, metastasis, survival, and resistance to anticancer therapies in many cancers[16], supporting the idea that the IGF system is an attractive therapeutic target. The gene discussed is IGF1; the disease is cancer.